Most clinicians arent surprised that GLP-1s need to be taken long-term
This could be due to a controversial belief that obesity isnt a disease, despite the American Medical Associations 2023 statement recognizing it as such
Hypoglycaemia: As monotherapy, the risk of hypoglycaemia with retatrutide is expected to be low, given its glucose-dependent mechanism of action
Anyone who is allergic to compounded GLP-1 therapy, or other ingredients found in compounded GLP-1 therapy is not a good candidate
Those expecting domestic-level service often end up frustrated regardless of product quality
To analyze postprandial incretin secretion, we fasted PAR2-mutant and WT mice overnight followed by refeeding of normal chow diet (NCD) for 1 hour, a reliable time point as determined by a pilot experiment in WT mice on both C57BL/6N and C57BL/6J backgrounds (Supplemental Figure 1B)